Mirena 52 MG systems
Ended Awarded
- Contract number
- SPE2DB26FEPTK
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,415
Award facts
- Contract value 100% obligated
- $10,415.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
On October 17, 2025, the Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $10,415.40 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg contraceptive systems. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will perform the work at its Park Ridge location. This delivery order was issued without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The contract is scheduled for ultimate completion on November 7, 2025.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to support the Department of Defense's pharmaceutical supply needs globally. The PPV-G GEN V contract, valued at approximately $500 million with a completion date of December 31, 2036, authorizes DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables. DMS Pharmaceutical Group's established performance across numerous recent delivery orders demonstrates its capability to fulfill the diverse pharmaceutical requirements of military healthcare facilities worldwide.
Quick answers
Who was awarded contract SPE2DB26FEPTK?
SPE2DB26FEPTK was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 17, 2025.
How much is contract SPE2DB26FEPTK worth?
The government has obligated $10,415 on SPE2DB26FEPTK.
Is contract SPE2DB26FEPTK an order under another contract?
Yes. SPE2DB26FEPTK is a delivery order under SPE2DB24D9113, an indefinite delivery contract.
Was contract SPE2DB26FEPTK competed?
The extent of competition for SPE2DB26FEPTK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award